VVOS

Vivos Therapeutics, Inc. · NASDAQ

Sector Health Technology
Industry Medical Specialties
Website vivos.com
Employees(FY) 154
ISIN US92859E2072

Performance

-9.97%

+8.24%

+11.15%

+26.2%

-76.77%

YTD

-32.48%

Profile

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was founded in 2016 and is based in Littleton, Colorado.

Advanced Technical Analysis

Technical Analysis of VVOS 2024-11-20

The Moving Average Score of 63 indicates a bullish sentiment, while the Oscillators Score of 50 and Technical Score of 56 suggest a more neutral to slightly bullish outlook. Overall, the combined scores reflect a cautiously optimistic sentiment in the stock, with the moving averages providing the strongest support for potential upward movement.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of VVOS

Stock Rank

Recent News & Updates

2024-11-14 15:00
Vivos Therapeutics Inc (VVOS) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ...(Yahoo Finance)
2024-11-14 03:05
Vivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational Update(Globenewswire)
2024-11-13 04:00
Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call(Globenewswire)
2024-10-07 19:30
Vivos Therapeutics Granted CPT Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association(Globenewswire)
2024-09-18 19:00
Vivos Therapeutics Announces Pricing of $4.3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules(Globenewswire)
2024-09-17 22:05
Vivos Therapeutics Says It Is Poised To Disrupt Pediatric Sleep Apnea Market, Secures FDA Approval For DNA Appliance To Treat Snoring In Children(Yahoo Finance)
2024-09-17 19:00
Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring(Globenewswire)
2024-08-14 04:05
Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update(Globenewswire)
2024-08-13 19:30
Vivos Therapeutics Schedules Release of Second Quarter 2024 Financial Results and Conference Call(Globenewswire)
2024-07-01 00:33
Vivos eyes human trials for radiation treatment gel with IDE submission(Yahoo Finance)
2024-06-26 19:30
Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model(Globenewswire)
2024-06-11 19:30
Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance(Globenewswire)
2024-05-20 01:04
Consolidated Water Comments on ISS and Glass Lewis Reports and Urges Stockholders to Vote FOR Re-Election of Its Highly Qualified Directors(Globenewswire)
2024-05-15 01:01
Vivos Therapeutics Inc (VVOS) Q1 2024 Earnings Call Transcript Highlights: Navigating ...(Yahoo Finance)
2024-05-14 19:29
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday(Investorplace)
2024-05-14 04:05
Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update(Globenewswire)
2024-05-13 19:30
Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call(Globenewswire)
2024-04-09 02:45
Vivos Therapeutics receives approval for Medicare reimbursement for flagship Oral Medical Devices(Newsdirect)
2024-04-08 20:53
Why Is Vivos Therapeutics (VVOS) Stock Up 16% Today?(Investorplace)
2024-04-08 19:30
Vivos Therapeutics' Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement(Globenewswire)
2024-04-01 00:53
Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q4 2023 Earnings Call Transcript(Insidermonkey)
2024-03-28 08:53
VVOS Stock Earnings: Vivos Therapeutics Misses EPS, Misses Revenue for Q4 2023(Investorplace)
2024-03-28 04:05
Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update(Globenewswire)
2024-03-27 19:30
Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call(Globenewswire)
2024-02-21 23:39
3 Stocks to Turn $1,000 Into $1 Million: February 2024(Yahoo Finance)
2024-02-14 19:00
Vivos Therapeutics Announces Exercise of Warrants for Approximately $4.0 Million Aggregate Gross Proceeds(Globenewswire)
2024-02-11 20:24
Vivos Therapeutics CEO Kirk Huntsman Discusses FDA Approval and Market Disruptions(Yahoo Finance)
2024-02-05 18:30
Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities(Globenewswire)
2024-01-07 18:30
Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company's Proprietary Oral Medical Devices to Treat Severe OSA(Globenewswire)
2023-12-10 18:30
Vivos Therapeutics Presents Groundbreaking Event: Empowering Women to Champion Airway(Globenewswire)

Page 1 of 5

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.